Reducing the risk of skin cancer could be as simple as rummaging through your medicine cabinet.
An extensive study out of Denmark reveals that painkillers like aspirin, Advil and Aleve could cut down the risk of developing the three major kinds of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma.
Researchers in Denmark looked at 179,000 people from the northern part of the country between 1991-2002. The study found that people who took two or more painkillers during the 11-year period were 15 percent less likely to develop squamous cell carcinoma and 13 percent less likely to develop malignant melanoma than those who took fewer painkillers.
With basal cell carcinoma, the most prolific type of skin cancer which affects two million Americans each year, the study found that long-term or intensive use of painkillers reduced the risk of developing the cancer on less-exposed parts of the body.
The researchers note the study does not prove cause and effect, and more research is needed to determine how these anti-inflammatory medications reduce cancer risk.